ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $269 | -58.3% | 300 | 0.0% | 0.00% | – |
Q2 2023 | $645 | +10.3% | 300 | 0.0% | 0.00% | – |
Q1 2023 | $585 | -49.2% | 300 | 0.0% | 0.00% | – |
Q4 2022 | $1,152 | +15.2% | 300 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 300 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $4,000 | -33.3% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $6,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $8,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |